m+Medelevator.RU
← Поиск публикаций
Chemical science · 2026

Modular in-plate synthesis of N-heterocycles for direct-to-biology screening.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Sun Xiaowei, Ye Zhantao, Guo Fusheng, Chu Xin, Chen Yu, Li Jing, Yang Tianxi, Zhao Beile, Zhang Bilin, Jiang Shuai, He Gang, Qiao Tianjiao, Lei Xiaoguang, Liu Hong, Chen Gong

Аннотация

Rapid functional discovery increasingly demands synthetic methods that are compatible with automation, high-throughput experimentation, and minimal operational complexity. Miniaturized parallel synthesis in multi-well microplates provides a compelling alternative to traditional combinatorial approaches, enabling streamlined workflows and direct biological testing of crude products without purification. However, synthetic strategies suitable for such direct-to-biology applications remain largely confined to a narrow set of crosslinking reactions, limiting access to complex, three-dimensional scaffolds central to drug discovery. Herein, we report a highly efficient and broadly applicable multicomponent cyclocondensation that enables the rapid, modular construction of multisubstituted 6-membered tetrahydrotriazine scaffolds from readily available aldehydes, amines, and hydrazines through simple mixing at room temperature. The reaction proceeds cleanly under mild conditions and is fully compatible with plate-based synthesis, allowing high-purity compound libraries to be generated and evaluated directly upon solvent removal. Using this "mixing-drying-biotesting" workflow, we rapidly constructed and screened pilot 1,3,5-tri-substituted tetrahydrotriazine libraries with diverse structures, leading to the identification of potent α1A-adrenoceptor antagonists. Together, this work demonstrates how the integration of novel synthetic chemistry with direct-to-biology screening can unlock previously unexplored heterocyclic chemical space and accelerate early-stage drug discovery, while reducing the time, cost, and experimental waste.